Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease

Molecular Neurodegeneration

Volumn 6, Issue 1, 2011, Pages

  Kedmi, Merav ^a   Bar Shira, Anat ^a   Gurevich, Tanya ^a,b   Giladi, Nir ^a,b   Orr Urtreger, Avi ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TRANSCRIPTOME;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; LEUKOCYTE; MALE; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PATHOGENESIS; REAL TIME POLYMERASE CHAIN REACTION;

EID: 80053174483     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-6-66     Document Type: Article

References (54)

1. Evidence for a common pathway linking neurodegenerative diseases. Shulman JM, De Jager PL, Nat Genet 2009 41 1261 1262 10.1038/ng1209-1261 19935760
2. Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. de Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, Fratiglioni L, Lobo A, Martinez-Lage J, Trenkwalder C, Hofman A, Neurology 2000 54 21 23 10854357
3. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, et al. Science 1997 276 2045 2047 10.1126/science.276.5321.2045 9197268 (Pubitemid 27443610)
4. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Lesage S, Brice A, Hum Mol Genet 2009 18 48 59 10.1093/hmg/ddp012 19297401
5. SnapShot: pathogenesis of Parkinson's disease. Shin JH, Dawson VL, Dawson TM, Cell 2009 139 440 e441-442 19837042
6. Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology. Simunovic F, Yi M, Wang Y, Macey L, Brown LT, Krichevsky AM, Andersen SL, Stephens RM, Benes FM, Sonntag KC, Brain 2009 132 1795 1809 10.1093/brain/awn323 19052140
7. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. Hauser MA, Li YJ, Xu H, Noureddine MA, Shao YS, Gullans SR, Scherzer CR, Jensen RV, McLaurin AC, Gibson JR, et al. Arch Neurol 2005 62 917 921 10.1001/archneur.62.6.917 15956162 (Pubitemid 40973453)
8. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. Grunblatt E, Mandel S, Jacob-Hirsch J, Zeligson S, Amariglo N, Rechavi G, Li J, Ravid R, Roggendorf W, Riederer P, Youdim MB, J Neural Transm 2004 111 1543 1573 10.1007/s00702-004-0212-1 15455214 (Pubitemid 40068786)
9. Molecular markers of early Parkinson's disease based on gene expression in blood. Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, Fefer D, Schwarzschild MA, Schlossmacher MG, Hauser MA, Vance JM, et al. Proc Natl Acad Sci USA 2007 104 955 960 10.1073/pnas.0610204104 17215369 (Pubitemid 46154718)
10. Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation. Mutez E, Larvor L, Lepretre F, Mouroux V, Hamalek D, Kerckaert JP, Perez-Tur J, Waucquier N, Vanbesien-Mailliot C, Duflot A, et al. Neurobiol Aging 2010
11. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A, et al. Nature 2008 452 638 642 10.1038/nature06846 18385739 (Pubitemid 351483366)
12. RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients. Orr-Urtreger A, Bar-Shira A, Bercovich D, Matarasso N, Rozovsky U, Rosner S, Soloviov S, Rennert G, Kadouri L, Hubert A, et al. Cancer Epidemiol Biomarkers Prev 2006 15 474 479 10.1158/1055-9965. EPI-05-0606 16537704
13. A genetic profile of contemporary Jewish populations. Ostrer H, Nat Rev Genet 2001 2 891 898 11715044 (Pubitemid 33674035)
14. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Orr-Urtreger A, Shifrin C, Rozovski U, Rosner S, Bercovich D, Gurevich T, Yagev-More H, Bar-Shira A, Giladi N, Neurology 2007 69 1595 1602 10.1212/01.wnl.0000277637.33328.d8 17938369 (Pubitemid 350287143)
15. Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Gan-Or Z, Giladi N, Rozovski U, Shifrin C, Rosner S, Gurevich T, Bar-Shira A, Orr-Urtreger A, Neurology 2008 70 2277 2283 10.1212/01.wnl.0000304039.11891.29 18434642
16. Gender differences in Parkinson's disease. Haaxma CA, Bloem BR, Borm GF, Oyen WJ, Leenders KL, Eshuis S, Booij J, Dluzen DE, Horstink MW, J Neurol Neurosurg Psychiatry 2007 78 819 824 10.1136/jnnp.2006.103788 17098842 (Pubitemid 47204585)
17. Heterogeneity in male to female risk for Parkinson's disease. Taylor KS, Cook JA, Counsell CE, J Neurol Neurosurg Psychiatry 2007 78 905 906 10.1136/jnnp.2006.104695 17635983 (Pubitemid 47204606)
18. Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Uc EY, McDermott MP, Marder KS, Anderson SW, Litvan I, Como PG, Auinger P, Chou KL, Growdon JC, Neurology 2009 73 1469 1477 10.1212/WNL.0b013e3181bf992f 19884574
19. Effects of gender on nigral gene expression and parkinson disease. Cantuti-Castelvetri I, Keller-McGandy C, Bouzou B, Asteris G, Clark TW, Frosch MP, Standaert DG, Neurobiol Dis 2007 26 606 614 10.1016/j.nbd.2007.02.009 17412603 (Pubitemid 46756328)
20. Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease. Duke DC, Moran LB, Kalaitzakis ME, Deprez M, Dexter DT, Pearce RK, Graeber MB, Neurogenetics 2006 7 139 148 10.1007/s10048-006-0033-5 16699787 (Pubitemid 44078291)
21. Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease. Moran LB, Duke DC, Deprez M, Dexter DT, Pearce RK, Graeber MB, Neurogenetics 2006 7 1 11 10.1007/s10048-005-0020-2 16344956 (Pubitemid 43327678)
22. Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Zhang Y, James M, Middleton FA, Davis RL, Am J Med Genet B Neuropsychiatr Genet 2005 137B 5 16 10.1002/ajmg.b.30195 15965975 (Pubitemid 41076605)
23. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Huang da W, Sherman BT, Lempicki RA, Nat Protoc 2009 4 44 57 19131956
24. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA, Genome Biol 2003 4 3 10.1186/gb-2003-4-5-p3 12734009
25. TRPML cation channels regulate the specialized lysosomal compartment of vertebrate B-lymphocytes. Song Y, Dayalu R, Matthews SA, Scharenberg AM, Eur J Cell Biol 2006 85 1253 1264 10.1016/j.ejcb.2006.08.004 17050035 (Pubitemid 44743148)
26. Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. McKenna F, McLaughlin PJ, Lewis BJ, Sibbring GC, Cummerson JA, Bowen-Jones D, Moots RJ, J Neuroimmunol 2002 132 34 40 10.1016/S0165-5728(02)00280-1 12417431 (Pubitemid 35333323)
27. Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Josefsson E, Bergquist J, Ekman R, Tarkowski A, Immunology 1996 88 140 146 10.1046/j.1365-2567.1996.d01-653.x 8707341 (Pubitemid 26166387)
28. Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease. Caronti B, Antonini G, Calderaro C, Ruggieri S, Palladini G, Pontieri FE, Colosimo C, J Neural Transm 2001 108 803 807 10.1007/s007020170030 11515746 (Pubitemid 32694403)
29. Increased expression of dopamine receptors on lymphocytes in Parkinson's disease. Barbanti P, Fabbrini G, Ricci A, Cerbo R, Bronzetti E, Caronti B, Calderaro C, Felici L, Stocchi F, Meco G, et al. Mov Disord 1999 14 764 771 10.1002/1531-8257(199909)14:5<764::AID-MDS1008>3.0.CO;2-W 10495037 (Pubitemid 29509618)
30. Neuroinflammation in Parkinson's disease: a target for neuroprotection? Hirsch EC, Hunot S, Lancet Neurol 2009 8 382 397 10.1016/S1474-4422(09)70062-6 19296921
31. Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism. Bas J, Calopa M, Mestre M, Mollevi DG, Cutillas B, Ambrosio S, Buendia E, J Neuroimmunol 2001 113 146 152 10.1016/S0165-5728(00)00422-7 11137586 (Pubitemid 32008680)
32. Altered lymphocyte distribution in Alzheimer's disease. Richartz-Salzburger E, Batra A, Stransky E, Laske C, Kohler N, Bartels M, Buchkremer G, Schott K, J Psychiatr Res 2007 41 174 178 10.1016/j.jpsychires. 2006.01.010 16516234 (Pubitemid 44708214)
33. Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. Mantovani S, Garbelli S, Pasini A, Alimonti D, Perotti C, Melazzini M, Bendotti C, Mora G, J Neuroimmunol 2009 210 73 79 10.1016/j.jneuroim.2009.02.012 19307024
34. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Wakabayashi K, Mori F, Tanji K, Orimo S, Takahashi H, Acta Neuropathol 120 1 12
35. Lesions outside the CNS in Parkinson's disease. Djaldetti R, Lev N, Melamed E, Mov Disord 2009 24 793 800 10.1002/mds.22172 19224610
36. Lymphocyte subsets' reference ranges in an age- and gender-balanced population of 100 healthy adults - a monocentric German study. Jentsch-Ullrich K, Koenigsmann M, Mohren M, Franke A, Clin Immunol 2005 116 192 197 10.1016/j.clim.2005.03.020 15993366 (Pubitemid 40910245)
37. Lymphocyte subset reference ranges in adult Caucasians. Reichert T, DeBruyere M, Deneys V, Totterman T, Lydyard P, Yuksel F, Chapel H, Jewell D, Van Hove L, Linden J, et al. Clin Immunol Immunopathol 1991 60 190 208 10.1016/0090-1229(91)90063-G 1712687
38. Aging and lymphocyte subpopulations: whole-blood analysis of immune markers in a large population sample of healthy elderly individuals. Huppert FA, Solomou W, O'Connor S, Morgan K, Sussams P, Brayne C, Exp Gerontol 1998 33 593 600 10.1016/S0531-5565(98)00033-3 9789736 (Pubitemid 128370103)
39. Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration. Andreadou E, Nikolaou C, Gournaras F, Rentzos M, Boufidou F, Tsoutsou A, Zournas C, Zissimopoulos V, Vassilopoulos D, Clin Neurol Neurosurg 2009 111 724 728 10.1016/j.clineuro.2009. 06.012 19632030
40. Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease. Simunovic F, Yi M, Wang Y, Stephens R, Sonntag KC, PLoS One 2010 5 8856 10.1371/journal.pone.0008856 20111594
41. LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease. Gan-Or Z, Bar-Shira A, Mirelman A, Gurevich T, Kedmi M, Giladi N, Orr-Urtreger A, Neurogenetics 2010 11 121 125 10.1007/s10048-009-0198- 9 19458969
42. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, et al. Nat Genet 2001 29 365 371 10.1038/ng1201-365 11726920 (Pubitemid 34326681)
43. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bolstad BM, Irizarry RA, Astrand M, Speed TP, Bioinformatics 2003 19 185 193 10.1093/bioinformatics/19.2.185 12538238 (Pubitemid 36181903)
44. Effect of polymorphisms within probe-target sequences on olignonucleotide microarray experiments. Benovoy D, Kwan T, Majewski J, Nucleic Acids Res 2008 36 4417 4423 10.1093/nar/gkn409 18596082
45. SNPinProbe-1.0: A database for filtering out probes in the Affymetrix GeneChip(R) Human Exon 1.0 ST array potentially affected by SNPs. Duan S, Zhang W, Bleibel WK, Cox NJ, Dolan ME, Bioinformation 2008 2 469 470 18841244
46. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T, Genome Res 2003 13 2498 2504 10.1101/gr.1239303 14597658 (Pubitemid 37428274)
47. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Zhang B, Kirov S, Snoddy J, Nucleic Acids Res 2005 33 741 748 10.1093/nar/gki475 15980575 (Pubitemid 44530021)
48. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Andersen CL, Jensen JL, Orntoft TF, Cancer Res 2004 64 5245 5250 10.1158/0008-5472.CAN-04- 0496 15289330 (Pubitemid 39006544)
49. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Livak KJ, Schmittgen TD, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609 (Pubitemid 34164012)
50. CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2. Pfisterer P, Konig H, Hess J, Lipowsky G, Haendler B, Schleuning WD, Wirth T, Mol Cell Biol 1996 16 6160 6168 8887646 (Pubitemid 26360976)
51. FcRH1: an activation coreceptor on human B cells. Leu CM, Davis RS, Gartland LA, Fine WD, Cooper MD, Blood 2005 105 1121 1126 15479727 (Pubitemid 40170884)
52. CD73 mediates adhesion of B cells to follicular dendritic cells. Airas L, Jalkanen S, Blood 1996 88 1755 1764 8781432 (Pubitemid 26307072)
53. Pax-5 is a key regulator of the B cell-restricted expression of the CD23a isoform. Visan I, Goller M, Berberich I, Kneitz C, Tony HP, Eur J Immunol 2003 33 1163 1173 10.1002/eji.200323747 12731041 (Pubitemid 36609134)
54. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Ishii KJ, Kawagoe T, Koyama S, Matsui K, Kumar H, Kawai T, Uematsu S, Takeuchi O, Takeshita F, Coban C, Akira S, Nature 2008 451 725 729 10.1038/nature06537 18256672 (Pubitemid 351220566)